Peficitinib, a JAK Inhibitor, in the Treatment of Moderate-to-severe Rheumatoid Arthritis in Methotrexate-inadequate Responders
Arthritis & Rheum 2016; ePub ahead of print
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Arthritis & Rheum 2016; ePub ahead of print
Ann Rheum Dis 2016;75:1979–83
Arthritis Res Ther 2016; 18:198. DOI.10.1186/s13075-016-9
Arthritis Rheumatol 2016; Accepted article DOI 10.1002/art-39808 [Epub 2016]
Arthritis Research & Therapy. 2016. DOI 10.1186/s13075-016-1049-3 [Epub ahead of print]
N Engl J Med. 2016 Mar 31;374(13):1243-52. doi: 10.1056/NEJMoa1507247
Arthritis Rheumatol. 2016 Jan;68(1):46-55.
Arthritis Rheumatol. Vol. 67, No. 6, June 2015, pp 1424–1437
Ann Rheum Dis. 2015;74(2):333–340
The New England Journal of Medicine 2010; 363(14):1303-12